Retrophin, LLC Announces Positive Results From Preclinical Studies of RE-024 for PKAN
3/11/2013 11:01:31 AM
More...
|
Retrophin, LLC Raises $10.0 Million in Private Placement
2/12/2013 9:50:31 AM
More...
|
Retrophin, LLC to Present at the 15th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/5/2013 6:07:16 AM
More...
|
Ligand Pharmaceuticals Inc. (LGND) Receives Equity Milestone Payment From Retrophin, LLC
1/9/2013 9:39:59 AM
More...
|
Retrophin, LLC to Present at Biotech Showcase 2013
12/27/2012 6:51:10 AM
More...
|
Retrophin, LLC Completes Reverse Merger With Desert Gateway, Inc.
12/18/2012 9:05:20 AM
More...
|
Retrophin, LLC Names Stephen Aselage as Chief Executive Officer
9/10/2012 9:19:32 AM
More...
|
Retrophin, LLC and St. Jude Children's Research Hospital to Collaborate on Rare Disease Research Program
7/16/2012 9:54:12 AM
More...
|
Retrophin, LLC Completes Series A Financing
5/7/2012 7:41:13 AM
More...
|